Floatz logo

DIPHTHERIA TOXOID

Fallopian Tube Endometrioid Adenocarcinoma

Mayo ClinicvaccinePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
81/ 100

Competitive context

22 Active assets in the Fallopian Tube Endometrioid Adenocarcinoma cohort.

Asset / SponsorPhaseRating
Carboplatin
National Cancer Institute (NCI)
Phase 3BB
Olaparib
NRG Oncology
Phase 3BB
CIS-DIAMMINEDICHLOROPLATINUM II
Ohio State University Comprehensive Cancer Center
Phase 3BB
Cyclophosphamide
Roswell Park Cancer Institute
Phase 2B
Inno-206
National Cancer Institute (NCI)
Phase 2/3B

View all 29 →

Same molecule, other indications

DIPHTHERIA TOXOID is also rated in:

relapsing-remitting multiple sclerosisDormant
B
Indicative ·
59 / 100
View asset →
multiple sclerosisDormant
CCC
Indicative ·
54 / 100
View asset →
fallopian tube carcinomaDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →